Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.

Bachet JB, Moreno-Lopez N, Vigano L, Marchese U, Gelli M, Raoux L, Truant S, Laurent C, Herrero A, Le Roy B, Deguelte Lardiere S, Passot G, Hautefeuille V, De La Fouchardiere C, Artru P, Ameto T, Mabrut JY, Schwarz L, Rousseau B, Lepère C, Coriat R, Brouquet A, Sa Cunha A, Benoist S.

Br J Surg. 2019 Aug;106(9):1237-1247. doi: 10.1002/bjs.11180. Epub 2019 Jun 10.

PMID:
31183866
2.

Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data.

Boulet S, Ursino M, Thall P, Landi B, Lepère C, Pernot S, Burgun A, Taieb J, Zaanan A, Zohar S, Jannot AS.

Stat Methods Med Res. 2019 Apr 9:962280219841082. doi: 10.1177/0962280219841082. [Epub ahead of print]

PMID:
30963815
3.

Diversity, spatial distribution and activity of fungi in freshwater ecosystems.

Lepère C, Domaizon I, Humbert JF, Jardillier L, Hugoni M, Debroas D.

PeerJ. 2019 Feb 21;7:e6247. doi: 10.7717/peerj.6247. eCollection 2019.

4.

Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study.

Pernot S, Dubreuil O, Aparicio T, Le Malicot K, Tougeron D, Lepère C, Lecaille C, Marthey L, Palle J, Bachet JB, Zaanan A, Taieb J.

Br J Cancer. 2018 Aug;119(4):424-428. doi: 10.1038/s41416-018-0133-7. Epub 2018 Jun 6.

5.

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.

André T, Vernerey D, Mineur L, Bennouna J, Desrame J, Faroux R, Fratte S, Hug de Larauze M, Paget-Bailly S, Chibaudel B, Bez J, Dauba J, Louvet C, Lepere C, Dupuis O, Becouarn Y, Mabro M, Egreteau J, Bouche O, Deplanque G, Ychou M, Galais MP, Ghiringhelli F, Dourthe LM, Bachet JB, Khalil A, Bonnetain F, de Gramont A, Taieb J; for PRODIGE investigators, GERCOR, Fédération Française de Cancérologie Digestive, and UNICANCER.

J Clin Oncol. 2018 May 20;36(15):1469-1477. doi: 10.1200/JCO.2017.76.0355. Epub 2018 Apr 5.

PMID:
29620995
6.

Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study.

Walter T, Malka D, Hentic O, Lombard-Bohas C, Le Malicot K, Smith D, Ferru A, Assenat E, Cadiot G, Lievre A, Kurtz JE, Dahan L, Dubreuil O, Hautefeuille V, Lepere C, Gangloff A, Elhajbi F, Coriat R, Roquin G, Bouarioua N, Granger V, Scoazec JY, Lepage C.

Dig Liver Dis. 2018 Feb;50(2):195-198. doi: 10.1016/j.dld.2017.11.020. Epub 2017 Dec 6.

PMID:
29258812
7.

5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.

Pernot S, Velut G, Kourie RH, Amouyal G, Sapoval M, Pointet AL, Landi B, Zaimi Y, Lepère C, Pellerin O, Taieb J.

Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):255-260. doi: 10.1016/j.clinre.2017.11.004. Epub 2017 Dec 7.

PMID:
29233520
8.

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.

Walter T, Tougeron D, Baudin E, Le Malicot K, Lecomte T, Malka D, Hentic O, Manfredi S, Bonnet I, Guimbaud R, Coriat R, Lepère C, Desauw C, Thirot-Bidault A, Dahan L, Roquin G, Aparicio T, Legoux JL, Lombard-Bohas C, Scoazec JY, Lepage C, Cadiot G; CEPD investigators.

Eur J Cancer. 2017 Jul;79:158-165. doi: 10.1016/j.ejca.2017.04.009. Epub 2017 May 11.

PMID:
28501762
9.

Overview of freshwater microbial eukaryotes diversity: a first analysis of publicly available metabarcoding data.

Debroas D, Domaizon I, Humbert JF, Jardillier L, Lepère C, Oudart A, Taïb N.

FEMS Microbiol Ecol. 2017 Apr 1;93(4). doi: 10.1093/femsec/fix023.

PMID:
28334157
10.

Temporal and spatial variations in the composition of freshwater photosynthetic picoeukaryotes revealed by MiSeq sequencing from flow cytometry sorted samples.

Li S, Bronner G, Lepère C, Kong F, Shi X.

Environ Microbiol. 2017 Jun;19(6):2286-2300. doi: 10.1111/1462-2920.13724. Epub 2017 Apr 3.

PMID:
28276185
11.

Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Aparicio T, Gargot D, Teillet L, Maillard E, Genet D, Cretin J, Locher C, Bouché O, Breysacher G, Seitz JF, Gasmi M, Stefani L, Ramdani M, Lecomte T, Auby D, Faroux R, Bachet JB, Lepère C, Khemissa F, Sobhani I, Boulat O, Mitry E, Jouve JL; FFCD 2001-02 investigators.

Eur J Cancer. 2017 Mar;74:98-108. doi: 10.1016/j.ejca.2016.09.029. Epub 2016 Nov 5.

PMID:
27825697
12.

Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.

Bouchahda M, Boige V, Smith D, Karaboué A, Ducreux M, Hebbar M, Lepère C, Focan C, Guimbaud R, Innominato P, Awad S, Carvalho C, Tumolo S, Truant S, De Baere T, Castaing D, Rougier P, Morère JF, Taieb J, Adam R, Lévi F; ARTBC International.

Eur J Cancer. 2016 Nov;68:163-172. doi: 10.1016/j.ejca.2016.09.011. Epub 2016 Oct 18.

PMID:
27768923
13.

Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?

Dréanic J, Lepère C, El Hajjam M, Gouya H, Rougier P, Coriat R.

Ther Adv Med Oncol. 2016 Sep;8(5):383-7. doi: 10.1177/1758834016656495. Epub 2016 Jul 5. Review.

14.

Distinct Spatial Patterns of SAR11, SAR86, and Actinobacteria Diversity along a Transect in the Ultra-oligotrophic South Pacific Ocean.

West NJ, Lepère C, Manes CL, Catala P, Scanlan DJ, Lebaron P.

Front Microbiol. 2016 Mar 8;7:234. doi: 10.3389/fmicb.2016.00234. eCollection 2016.

15.

Diversity and Dynamics of Active Small Microbial Eukaryotes in the Anoxic Zone of a Freshwater Meromictic Lake (Pavin, France).

Lepère C, Domaizon I, Hugoni M, Vellet A, Debroas D.

Front Microbiol. 2016 Feb 10;7:130. doi: 10.3389/fmicb.2016.00130. eCollection 2016.

16.

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.

Lévi FA, Boige V, Hebbar M, Smith D, Lepère C, Focan C, Karaboué A, Guimbaud R, Carvalho C, Tumolo S, Innominato P, Ajavon Y, Truant S, Castaing D, De Baere T, Kunstlinger F, Bouchahda M, Afshar M, Rougier P, Adam R, Ducreux M; Association Internationale pour Recherche sur Temps Biologique et Chronothérapie (ARTBC International).

Ann Oncol. 2016 Feb;27(2):267-74. doi: 10.1093/annonc/mdv548. Epub 2015 Nov 16.

PMID:
26578731
17.

Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues Oncologues.

Brieau B, Lepère C, Walter T, Lecomte T, Guimbaud R, Manfredi S, Tougeron D, Desseigne F, Lourenco N, Afchain P, El Hajbi F, Terris B, Rougier P, Coriat R.

Medicine (Baltimore). 2015 Oct;94(42):e1864. doi: 10.1097/MD.0000000000001864.

18.

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02).

Aparicio T, Lavau-Denes S, Phelip JM, Maillard E, Jouve JL, Gargot D, Gasmi M, Locher C, Adhoute X, Michel P, Khemissa F, Lecomte T, Provençal J, Breysacher G, Legoux JL, Lepère C, Charneau J, Cretin J, Chone L, Azzedine A, Bouché O, Sobhani I, Bedenne L, Mitry E; FFCD investigators.

Ann Oncol. 2016 Jan;27(1):121-7. doi: 10.1093/annonc/mdv491. Epub 2015 Oct 20.

PMID:
26487578
19.

In situ associations between marine photosynthetic picoeukaryotes and potential parasites - a role for fungi?

Lepère C, Ostrowski M, Hartmann M, Zubkov MV, Scanlan DJ.

Environ Microbiol Rep. 2016 Aug;8(4):445-51. doi: 10.1111/1758-2229.12339. Epub 2015 Dec 1.

PMID:
26420747
20.

Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort.

Portal A, Pernot S, Tougeron D, Arbaud C, Bidault AT, de la Fouchardière C, Hammel P, Lecomte T, Dréanic J, Coriat R, Bachet JB, Dubreuil O, Marthey L, Dahan L, Tchoundjeu B, Locher C, Lepère C, Bonnetain F, Taieb J.

Br J Cancer. 2015 Sep 29;113(7):989-95. doi: 10.1038/bjc.2015.328. Epub 2015 Sep 15.

21.

[Adjuvant treatment for resected colon cancer].

Pointet AL, Lepère C, Taieb J.

Rev Prat. 2015 Jun;65(6):789-92. French.

PMID:
26298901
22.

Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial.

Ducreux M, Dahan L, Smith D, O'Toole D, Lepère C, Dromain C, Vilgrain V, Baudin E, Lombard-Bohas C, Scoazec JY, Seitz JF, Bitoun L, Koné S, Mitry E.

Eur J Cancer. 2014 Dec;50(18):3098-106. doi: 10.1016/j.ejca.2014.10.002. Epub 2014 Oct 27.

PMID:
25454412
23.

Management of patients over 80 years of age treated with resection for localised colon cancer: results from a French referral centre.

Lièvre A, Laurent V, Cudennec T, Peschaud F, Malafosse R, Benoist S, Penna C, Lepère C, Vaillant JN, Julié C, Teillet L, Nordlinger B, Rougier P, Mitry E.

Dig Liver Dis. 2014 Sep;46(9):838-45. doi: 10.1016/j.dld.2014.05.005. Epub 2014 Jun 5.

PMID:
24908573
24.

Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy.

Portal A, Pernot S, Siauve N, Landi B, Lepère C, Colussi O, Rougier P, Zaanan A, Verrière B, Taieb J.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):e23-6. doi: 10.1016/j.clinre.2014.01.005. Epub 2014 Feb 18.

PMID:
24559766
25.

Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.

Touchefeu Y, Archambeaud I, Landi B, Lièvre A, Lepère C, Rougier P, Mitry E.

Dig Liver Dis. 2014 Mar;46(3):283-6. doi: 10.1016/j.dld.2013.10.012. Epub 2013 Nov 20.

PMID:
24268567
26.

In situ interactions between photosynthetic picoeukaryotes and bacterioplankton in the Atlantic Ocean: evidence for mixotrophy.

Hartmann M, Zubkov MV, Scanlan DJ, Lepère C.

Environ Microbiol Rep. 2013 Dec;5(6):835-40. doi: 10.1111/1758-2229.12084. Epub 2013 Jul 22.

PMID:
24249292
27.

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.

Pernot S, Mitry E, Samalin E, Dahan L, Dalban C, Ychou M, Seitz JF, Turki H, Mazard T, Zaanan A, Lepère C, Vaillant JN, Landi B, Rougier P, Taieb J.

Gastric Cancer. 2014 Apr;17(2):341-7. doi: 10.1007/s10120-013-0266-6. Epub 2013 Jun 6.

PMID:
23739764
28.

Digestive neuroendocrine tumors (DNET): the era of targeted therapies.

Boussaha T, Rougier P, Taieb J, Lepere C.

Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):134-41. doi: 10.1016/j.clinre.2012.09.010. Epub 2013 Apr 3. Review.

PMID:
23562338
29.

Geographic distance and ecosystem size determine the distribution of smallest protists in lacustrine ecosystems.

Lepère C, Domaizon I, Taïb N, Mangot JF, Bronner G, Boucher D, Debroas D.

FEMS Microbiol Ecol. 2013 Jul;85(1):85-94. doi: 10.1111/1574-6941.12100. Epub 2013 Mar 18.

30.

Dynamics of ammonia-oxidizing Archaea and Bacteria in contrasted freshwater ecosystems.

Hugoni M, Etien S, Bourges A, Lepère C, Domaizon I, Mallet C, Bronner G, Debroas D, Mary I.

Res Microbiol. 2013 May;164(4):360-70. doi: 10.1016/j.resmic.2013.01.004. Epub 2013 Feb 8.

PMID:
23395876
31.

A global perspective on marine photosynthetic picoeukaryote community structure.

Kirkham AR, Lepère C, Jardillier LE, Not F, Bouman H, Mead A, Scanlan DJ.

ISME J. 2013 May;7(5):922-36. doi: 10.1038/ismej.2012.166. Epub 2013 Jan 31.

32.

Chemosensitivity in ovarian metastases from gastric cancer: a case series.

Brieau B, Roussel H, Markoutsaki T, Dubreuil O, Trouilloud I, Landi B, Lepère C, Vaillant JN, Berger A, Rougier P, Taieb J, Zaanan A.

Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):289-95. doi: 10.1016/j.clinre.2012.09.007. Epub 2012 Nov 9.

PMID:
23142590
33.

Short-term responses of unicellular planktonic eukaryotes to increases in temperature and UVB radiation.

Domaizon I, Lepère C, Debroas D, Bouvy M, Ghiglione JF, Jacquet S, Bettarel Y, Bouvier C, Torréton JP, Vidussi F, Mostajir B, Kirkham A, Lefloc'h E, Fouilland E, Montanié H, Bouvier T.

BMC Microbiol. 2012 Sep 11;12:202. doi: 10.1186/1471-2180-12-202.

34.

An unusual recurrence site for HCC!

Auclin E, Camiliéri C, Dubreuil O, Lepère C, Zannan A, Rougier P, Taieb J.

Clin Res Hepatol Gastroenterol. 2013 Feb;37(1):e29-31. doi: 10.1016/j.clinre.2012.05.008. Epub 2012 Jul 4.

PMID:
22766151
35.

Metagenomes of the picoalga Bathycoccus from the Chile coastal upwelling.

Vaulot D, Lepère C, Toulza E, De la Iglesia R, Poulain J, Gaboyer F, Moreau H, Vandepoele K, Ulloa O, Gavory F, Piganeau G.

PLoS One. 2012;7(6):e39648. doi: 10.1371/journal.pone.0039648. Epub 2012 Jun 22.

36.

Plastid 16S rRNA gene diversity among eukaryotic picophytoplankton sorted by flow cytometry from the South Pacific Ocean.

Shi XL, Lepère C, Scanlan DJ, Vaulot D.

PLoS One. 2011 Apr 28;6(4):e18979. doi: 10.1371/journal.pone.0018979.

37.

Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine.

Trouilloud I, Dubreuil O, Boussaha T, Lepère C, Landi B, Zaanan A, Bachet JB, Taieb J.

Clin Res Hepatol Gastroenterol. 2011 May;35(5):364-74. doi: 10.1016/j.clinre.2011.02.002. Epub 2011 Mar 23. Review.

PMID:
21435966
38.

Whole-genome amplification (WGA) of marine photosynthetic eukaryote populations.

Lepere C, Demura M, Kawachi M, Romac S, Probert I, Vaulot D.

FEMS Microbiol Ecol. 2011 Jun;76(3):513-23. doi: 10.1111/j.1574-6941.2011.01072.x. Epub 2011 Mar 16.

39.

Vertical structure of small eukaryotes in three lakes that differ by their trophic status: a quantitative approach.

Lepère C, Masquelier S, Mangot JF, Debroas D, Domaizon I.

ISME J. 2010 Dec;4(12):1509-19. doi: 10.1038/ismej.2010.83. Epub 2010 Jun 24.

PMID:
20574460
40.

Autoimmune pancreatitis with atypical imaging findings that mimicked an endocrine tumor.

Neuzillet C, Lepère C, El Hajjam M, Palazzo L, Fabre M, Turki H, Hammel P, Rougier P, Mitry E.

World J Gastroenterol. 2010 Jun 21;16(23):2954-8.

41.

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study.

Lièvre A, Samalin E, Mitry E, Assenat E, Boyer-Gestin C, Lepère C, Bachet JB, Portales F, Vaillant JN, Ychou M, Rougier P.

BMC Cancer. 2009 Sep 28;9:347. doi: 10.1186/1471-2407-9-347.

42.

Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: feasibility and potential benefits in a retrospective series of 117 patients.

Bachet JB, Mitry E, Lièvre A, Lepère C, Vaillant JN, Declety G, Parlier H, Emile JF, Julié C, Rougier P.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):1036-44. doi: 10.1016/j.gcb.2009.03.017. Epub 2009 Sep 15.

43.

Photosynthetic picoeukaryote community structure in the South East Pacific Ocean encompassing the most oligotrophic waters on Earth.

Lepère C, Vaulot D, Scanlan DJ.

Environ Microbiol. 2009 Dec;11(12):3105-17. doi: 10.1111/j.1462-2920.2009.02015.x. Epub 2009 Aug 5.

PMID:
19674042
44.

Community structure and dynamics of small eukaryotes targeted by new oligonucleotide probes: new insight into the lacustrine microbial food web.

Mangot JF, Lepère C, Bouvier C, Debroas D, Domaizon I.

Appl Environ Microbiol. 2009 Oct;75(19):6373-81. doi: 10.1128/AEM.00607-09. Epub 2009 Aug 7.

45.

Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study.

Attal N, Bouhassira D, Gautron M, Vaillant JN, Mitry E, Lepère C, Rougier P, Guirimand F.

Pain. 2009 Aug;144(3):245-52. doi: 10.1016/j.pain.2009.03.024. Epub 2009 May 19.

PMID:
19457614
46.

Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.

Régeard M, Trotard M, Lepère C, Gripon P, Le Seyec J.

J Viral Hepat. 2008 Dec;15(12):865-70. doi: 10.1111/j.1365-2893.2008.01048.x.

PMID:
19087225
47.

[Small hepatocellular carcinoma revealed by peritoneal carcinosis].

Cosconea S, Mitry E, Emile JF, Parlier D, Lacout A, Lepère C, Chagnon S, Rougier P.

Gastroenterol Clin Biol. 2008 May;32(5 Pt 1):499-501. doi: 10.1016/j.gcb.2008.02.025. Epub 2008 May 7. French. No abstract available.

48.

Unexpected importance of potential parasites in the composition of the freshwater small-eukaryote community.

Lepère C, Domaizon I, Debroas D.

Appl Environ Microbiol. 2008 May;74(10):2940-9. doi: 10.1128/AEM.01156-07. Epub 2008 Mar 21.

49.

Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.

Mansencal N, Mitry E, Pillière R, Lepère C, Gérardin B, Petit J, Gandjbakhch I, Rougier P, Dubourg O.

Am J Cardiol. 2008 Apr 1;101(7):1035-8. doi: 10.1016/j.amjcard.2007.11.056. Epub 2008 Feb 11.

PMID:
18359327
50.

Risk of venous thrombosis in patients with pancreatic adenocarcinoma.

Mitry E, Taleb-Fayad R, Deschamps A, Mansencal N, Lepère C, Declety G, Lièvre A, Vaillant JN, Lesur G, Cramer E, Dubourg O, Rougier P.

Gastroenterol Clin Biol. 2007 Dec;31(12):1139-42.

Supplemental Content

Loading ...
Support Center